Abstract:Abstract BACKGROUND AND AIMS Atherogenic index of plasma (AIP), a logarithmically transformed ratio of triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C), is a biomarker of dyslipidemia and cardiovascular disease (CVD) risk. However, its applicability in end-stage kidney disease (ESKD) is not clear. We examined the association of AIP with all-cause and CVD mortality in two cohorts of ESKD patients, one from China and one from Sweden. METHOD In 1276 Chinese incident peritoneal dialysis (PD) patients (median age 50 years, 56% males) and 559 Swedish ESKD patients starting on dialysis (n = 392) or undergoing hemodialysis (n = 109) or PD 58 (median age 58 years, 62% males), baseline AIP and other biochemical and metabolic biomarkers were analysed in relation to mortality during follow-up period of up to 5 years. All-cause and CVD mortality risk were analysed with competing-risk regression models with transplantation as competing risk adjusting for age, sex, smoking, diabetes, serum albumin, hemoglobulin and calendar year. RESULTS Chinese patients [median (IQR) BMI 21 (19–23) kg/m2 TG 1.4 (1.0–1.8) and HDL-C 1.0 (0.9–1.3) mmol/L] compared with Swedish patients [median (IQR) BMI 24 (22–28)] kg/m2 TG 1.6 (1.2–2.2) and HDL-C 1.2 (1.0–1.6) mmol/L] were significantly younger (P < 0.01) and had lower BMI (P < 0.01), TG (P < 0.001), HDL-C (P < 0.001), and Framingham risk score (P < 0.01) while sex distribution was similar. ‘Chinese patients’: After median 3.6 years of follow-up, all-cause mortality rate was 16%, and 91 (46%) of the 199 deaths were caused by CVD. The highest tertile of AIP was associated with higher all-cause [sub-hazard ratio sHR (95% CI) 1.52 (1.05); Fig. 1A] and CVD mortality [sHR 1.82 (1.02–3.27); Fig. 1B] risk, after adjusting for confounders. ‘Swedish patients’: After median 2.1 years of follow-up, all-cause mortality rate was 36%, and 89 (44%) of the 204 deaths were caused by CVD. The highest tertile of AIP was associated with lower all-cause [sHR 0.66 (0.47–0.94); Fig. 2A] and CVD mortality [sHR 0.59 (0.35–0.97); Fig. 2B] risk after adjusting for confounders. CONCLUSION The highest tertile of AIP was independently associated with higher mortality risk in Chinese ESKD patients while it was associated with lower mortality risk in Swedish ESKD patients suggesting that AIP is context dependent, which limits is usefulness as a risk-assessment tool for predicting clinical outcomes in ESKD patients.

The Predictive Value of Atherogenic Index of Plasma, Non- High Density Lipoprotein Cholesterol (Non-HDL-C), Non-HDL-C/HDL-C, and Lipoprotein Combine Index for Stroke Incidence and Prognosis in Maintenance Hemodialysis Patients

MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts

Atherogenic Index of Plasma Predicts Outcomes in Acute Ischemic Stroke

Stroke Prognosis: the Impact of Combined Thrombotic, Lipid, and Inflammatory Markers

Accumulation of Circulating Advanced Oxidation Protein Products is an Independent Risk Factor for Ischaemic Heart Disease in Maintenance Haemodialysis Patients

Association between lipoprotein (a) and risk of atherosclerotic cardiovascular disease events among maintenance hemodialysis patients in Beijing, China: a single-center, retrospective study

The Association between Baseline Serum Lipids and Mortality in Peritoneal Dialysis Patients

The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease

Prognostic Efficacy of Combined Index of Cardiac Biomarkers for Cardiovascular and All-Cause Mortality on Hemodialysis Patients

Importance of Lipid Ratios for Predicting Intracranial Atherosclerotic Stenosis

What's the Optimal Lipids Level for Dialysis Patients? A Cohort Study from a Chinese Dialysis Center in a University Hospital.

The predictive value of systemic immune-inflammation index for vascular access survival in chronic hemodialysis patients

Lipoprotein(a) as a novel biomarker for predicting adverse outcomes in ischemic heart failure

Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study

The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Myeloperoxidase to high-density lipoprotein ratio: Potential predictor of severity and outcome in patients with acute ischemic stroke

Low-Density Lipoprotein Cholesterol to Triglyceride Ratio and Clinical Outcomes after Acute Ischaemic Stroke or Transient Ischaemic Attack.

Left Ventricular Mass Index And Aortic Arch Calcification Score Are Independent Mortality Predictors Of Maintenance Hemodialysis Patients

Abstract 10921: The Relationship Between Lipoprotein(a) and Cardiovascular Events in Chronic Kidney Disease Patients Hospitalized for Acute Coronary Syndrome

Association between the atherogenic index of plasma and adverse long-term prognosis in patients diagnosed with chronic coronary syndrome

Atherogenic index of plasma: a new indicator for assessing the short-term mortality of patients with acute decompensated heart failure